Suchergebnisse - "Taplin, Mary-Ellen"

PubPharm (279)

1

Postradical prostatectomy prostate-specific antigen outcomes after 6 versus 18 months of perioperative androgen-deprivation therapy in men with localized, unfavorable intermediate-risk or high-risk prostate cancer : Results of part 2 of a randomized phase 2 trial

enthalten in: Cancer | 2024

von McKay, R. | Xie, W. | Yang, X. | +16

2

PRESTO : A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19)

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Aggarwal, R. | Heller, G. | Hillman, D. | +70

CommentIn: Nat Rev Urol. 2024 Mar;21(3):126. - PMID 38355924

3

Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer

enthalten in: Cancer immunology research | 2024

von Choudhury, A. | Kwak, L. | Cheung, A. | +23

4

Molecular features of prostate cancer after neoadjuvant therapy in the phase 3 CALGB 90203 trial

enthalten in: Journal of the National Cancer Institute | 2024

von Sumiyoshi, T. | Wang, X. | Warner, E. | +15

CommentIn: J Natl Cancer Inst. 2023 Oct 10;:. - PMID 37816132

5

Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer : the COMBAT phase II trial

enthalten in: Nature communications | 2024

von Markowski, M. | Taplin, M. | Aggarwal, R. | +17

6

Adjuvant and salvage radiotherapy after neoadjuvant therapy and radical prostatectomy for high-risk localized prostate cancer

enthalten in: The Prostate | 2024

von Ravi, P. | Kwak, L. | Devlies, W. | +8

7

Adjuvant and salvage radiotherapy after neoadjuvant therapy and radical prostatectomy for high‐risk localized prostate cancer

enthalten in: The Prostate | 2024

von Ravi, P. | Kwak, L. | Devlies, W. | +8

8

Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker

enthalten in: Cancer discovery | 2023

von Taylor, M. | Wu, C. | Fridy, P. | +56

UpdateOf: bioRxiv. 2023 Mar 17;:. - PMID 36747644

9

Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer

enthalten in: European urology oncology | 2023

von Orme, J. | Taza, F. | De Sarkar, N. | +34

10

Pretest Video Education Versus Genetic Counseling for Patients With Prostate Cancer : ProGen, A Multisite Randomized Controlled Trial

enthalten in: JCO oncology practice | 2023

von Rana, H. | Stopfer, J. | Weitz, M. | +31

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[28]